GlassScriptPhysician profile
Nicole W Karjane
NPI 1942390646
$34,106.15
in general payments reported to CMS, 2019-2025
6 companies · $6,084 in 2025
The $6,084 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,059 · 2020: $1,426 · 2021: $4,138 · 2022: $4,372 · 2023: $4,701 · 2024: $7,326 · 2025: $6,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $17K · Travel and Lodging: $340 · Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $17,480.90 |
| Travel and Lodging | $340.20 |
| Food and Beverage | $290.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $26,572.21 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $7,300.78 | 2019-2020 | |
| Hologic Sales and Service, LLC | $159.46 | 2019-2022 | |
| Davol INC. | $36.99 | 2023 | Arista Ah Flexitip |
| Amag Pharmaceuticals, INC. | $25.12 | 2019 | |
| Exeltis, USA INC. | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Karjane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.